Giving anti-vitals early is a significant problem for covid-19 because such a significant numbers of patients will have no or mild symptoms (85%). So it’s real

Giving anti-vitals early is a significant problem for covid-19 because such a significant numbers of patients will have no or mild symptoms (85%). So it’s really a no-win situation because if you give it early, not many people will look like they’re getting better relative to control. But if you give it too late to those who have severe symptoms it will be too late. What they need to do is figure out a way to identify who will get severe symptoms and give remdesivir to them early. That’s probably the only way you will see a benefit, If there’s even a benefit at all.